KENNEY CHRISTOPHER JOHN (Chief Medical Officer) sold 16.6% of their position (1.41K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $77.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0001193125-26-106727
Officer· Chief Medical Officer
Since Aug 2021
-1.41K
Net shares
Net seller
$77.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.75K acquired · 5.16K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
79.3%
3/12/2026
4.73K→8.48K
Common Shares
Direct
Shares
−1.41K
Price / share
$55.23
Trade value
$77.87K
% of position
16.6%
3/13/2026
8.48K→7.07K
Total
Net shares
+2.34K
Net value
-$77.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/12/2026 | M · Option Exercise | +3.75K | — | — | 79.3% | 4.73K | 8.48K |
| Common Shares Direct | 3/13/2026 | S · Sale | −1.41K | $55.23 | $77.87K | 16.6% | 8.48K | 7.07K |
| Total | +2.34K | -$77.87K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Common Shares
3.75K shares
Shares
−3.75K
Strike price
Held after
11.25K
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Common Shares3.75K shares | 3/12/2026 | M · Option Exercise | −3.75K | — | 11.25K |